These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4301425)

  • 61. Equine interferon: characterization of a viral inhibitor induced in equine kidney cell cultures with statolon.
    Ley KD; Burger D; Henson JB
    J Infect Dis; 1970 Mar; 121(3):335-8. PubMed ID: 4313279
    [No Abstract]   [Full Text] [Related]  

  • 62. Interferon-mediated inhibition of virion-directed transcription.
    Manders EK; Tilles JG; Huang AS
    Virology; 1972 Aug; 49(2):573-81. PubMed ID: 4115403
    [No Abstract]   [Full Text] [Related]  

  • 63. Some factors affecting the interferon-induced antiviral state.
    Baron S; Buckler CE; Levy HB; Friedman RM
    Proc Soc Exp Biol Med; 1967; 125(4):1320-6. PubMed ID: 4167135
    [No Abstract]   [Full Text] [Related]  

  • 64. Inhibition of interferon action by actinomycin.
    Taylor J
    Biochem Biophys Res Commun; 1964; 14():447-51. PubMed ID: 4158168
    [No Abstract]   [Full Text] [Related]  

  • 65. Regulation of interferon action in human fibroblasts: transient induction of specific proteins and amplification of the antiviral response by antinomycin D.
    Gupta SL; Rubin BY; Holmes SL
    Virology; 1981 Jun; 111(2):331-40. PubMed ID: 6166117
    [No Abstract]   [Full Text] [Related]  

  • 66. Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus.
    Morahan PS; Grossberg SE
    J Infect Dis; 1970 Jun; 121(6):615-23. PubMed ID: 4316147
    [No Abstract]   [Full Text] [Related]  

  • 67. Intracellular events in the replication of defective interfering particles of vesicular stomatitis virus.
    Moyer SA; Gatchell SH
    Virology; 1979 Jan; 92(1):168-79. PubMed ID: 217161
    [No Abstract]   [Full Text] [Related]  

  • 68. Intrinsic interference between different enveloped RNA viruses.
    Rott R; Scholtissek C; Klenk HD; Kaluza G
    J Gen Virol; 1972 Dec; 17(3):255-64. PubMed ID: 4346650
    [No Abstract]   [Full Text] [Related]  

  • 69. RNA synthesis in BHK 21 cells persistently infected with vesicular stomatitis virus and rabies virus.
    Villarreal LP; Holland JJ
    J Gen Virol; 1976 Nov; 33(2):213-24. PubMed ID: 186560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interfering and interferon-inducing capacity of NDV. I. Quantitative analysis and physicochemical characteristics.
    Shu HL
    Arch Gesamte Virusforsch; 1974; 46(3-4):179-90. PubMed ID: 4375441
    [No Abstract]   [Full Text] [Related]  

  • 71. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
    Hoshino M; Taira H; Hattori S; Kawakita M
    J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interference activity and sensitivity to interferon of original and "cold" strains of adenovirus types 1 and 2.
    Lysov VV; Aksenov OA; Rudenko VI; Moshkin SA; Yurlova TI; Smorodintsev AA; Selivanov AA
    Acta Virol; 1971 Sep; 15(5):387-92. PubMed ID: 4399137
    [No Abstract]   [Full Text] [Related]  

  • 73. Decay of vesicular stomatitis virus mRNAs in vivo.
    Pennica D; Lynch KR; Cohen PS; Ennis HL
    Virology; 1979 Apr; 94(2):484-7. PubMed ID: 222066
    [No Abstract]   [Full Text] [Related]  

  • 74. [Thermosensitive mutants of vesicular stomatitis virus of complementation group II (author's transl)].
    Flamand A; Lafay F
    Ann Microbiol (Paris); 1973 Mar; 124(2):261-9. PubMed ID: 4355956
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of glucosamine treatment on vesicular stomatitis virus macromolecular synthesis: host cell dependence.
    Marnell LL; Wertz GW
    Virology; 1979 Oct; 98(1):88-98. PubMed ID: 225871
    [No Abstract]   [Full Text] [Related]  

  • 76. Coupled transcription and translation in mammalian and avian cell-free systems.
    Ball LA; White CN
    Virology; 1978 Feb; 84(2):479-95. PubMed ID: 203097
    [No Abstract]   [Full Text] [Related]  

  • 77. Studies of the induction of interferon system by nonreplicating Newcastle disease virus.
    Dianzani F; Gagnoni S; Buckler CE; Baron S
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):324-8. PubMed ID: 5460909
    [No Abstract]   [Full Text] [Related]  

  • 78. Origin and possible mode of action of a tissue antagonist of interferon.
    Fournier F; Chany C; Sarragne M
    Nat New Biol; 1972 Jan; 235(54):47-8. PubMed ID: 4332804
    [No Abstract]   [Full Text] [Related]  

  • 79. Potentiation of the antiviral activity of interferon by actinomycin D.
    Chany C; Fournier F; Rousset S
    Nat New Biol; 1971 Mar; 230(12):113-4. PubMed ID: 4323631
    [No Abstract]   [Full Text] [Related]  

  • 80. Effect of crude and purified interferons on the gowth of uninfected cells in culture.
    Baron S; Merigan TC; McKerlie ML
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):50-2. PubMed ID: 4285508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.